- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2051-1426
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Cytokine release syndrome ; volume:6 ; number:1 ; day:15 ; month:6 ; year:2018 ; pages:1-14 ; date:12.2018
Journal for ImmunoTherapy of Cancer ; 6, Heft 1 (15.6.2018), 1-14, 12.2018
- Urheber
-
Shimabukuro-Vornhagen, Alexander
- Beteiligte Personen und Organisationen
-
Gödel, Philipp
Subklewe, Marion
Stemmler, Hans Joachim
Schlößer, Hans Anton
Schlaak, Max
Kochanek, Matthias
Böll, Boris
von Bergwelt-Baildon, Michael S.
SpringerLink (Online service)
- DOI
-
10.1186/s40425-018-0343-9
- URN
-
urn:nbn:de:101:1-2018082420205103435543
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:33 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Shimabukuro-Vornhagen, Alexander
- Gödel, Philipp
- Subklewe, Marion
- Stemmler, Hans Joachim
- Schlößer, Hans Anton
- Schlaak, Max
- Kochanek, Matthias
- Böll, Boris
- von Bergwelt-Baildon, Michael S.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Cytokine release syndrome after bronchoalveolar lavage
Cytokine release syndrome: grading, modeling, and new therapy
The Many Faces of Cytokine Release Syndrome-Related Coagulopathy
First Case of Cytokine Release Syndrome after Nivolumab for Gastric Cancer
Cytokine-based models for efficient differentiation between infection and cytokine release syndrome in patients with hematological malignancies
Biomarkers of cytokine release syndrome and neurotoxicity related to CAR-T cell therapy
Cytokine release syndrome after radiation therapy: case report and review of the literature
Grading of cytokine release syndrome associated with the CAR T cell therapy tisagenlecleucel
Prophylactic tocilizumab to prevent cytokine release syndrome (CRS) with teclistamab: A single-center experience
Predominant cerebral cytokine release syndrome in CD19-directed chimeric antigen receptor-modified T cell therapy
Melatonin as an immunomodulator in CD19-targeting CAR-T cell therapy: managing cytokine release syndrome
Correction to: Grading of cytokine release syndrome associated with the CAR T cell therapy tisagenlecleucel
Cytokine release syndrome after bronchoalveolar lavage
Cytokine release syndrome: grading, modeling, and new therapy
The Many Faces of Cytokine Release Syndrome-Related Coagulopathy
First Case of Cytokine Release Syndrome after Nivolumab for Gastric Cancer
Cytokine-based models for efficient differentiation between infection and cytokine release syndrome in patients with hematological malignancies
Biomarkers of cytokine release syndrome and neurotoxicity related to CAR-T cell therapy
Cytokine release syndrome after radiation therapy: case report and review of the literature
Grading of cytokine release syndrome associated with the CAR T cell therapy tisagenlecleucel
Prophylactic tocilizumab to prevent cytokine release syndrome (CRS) with teclistamab: A single-center experience
Predominant cerebral cytokine release syndrome in CD19-directed chimeric antigen receptor-modified T cell therapy
Melatonin as an immunomodulator in CD19-targeting CAR-T cell therapy: managing cytokine release syndrome
Correction to: Grading of cytokine release syndrome associated with the CAR T cell therapy tisagenlecleucel
Cytokine release syndrome after bronchoalveolar lavage
Cytokine release syndrome: grading, modeling, and new therapy
The Many Faces of Cytokine Release Syndrome-Related Coagulopathy
First Case of Cytokine Release Syndrome after Nivolumab for Gastric Cancer
Cytokine-based models for efficient differentiation between infection and cytokine release syndrome in patients with hematological malignancies
Biomarkers of cytokine release syndrome and neurotoxicity related to CAR-T cell therapy
Cytokine release syndrome after radiation therapy: case report and review of the literature
Grading of cytokine release syndrome associated with the CAR T cell therapy tisagenlecleucel
Prophylactic tocilizumab to prevent cytokine release syndrome (CRS) with teclistamab: A single-center experience
Predominant cerebral cytokine release syndrome in CD19-directed chimeric antigen receptor-modified T cell therapy
Melatonin as an immunomodulator in CD19-targeting CAR-T cell therapy: managing cytokine release syndrome